Haptoglobin is an acute-phase glycoprotein that binds free hemoglobin released during red blood cell breakdown, preventing oxidative damage and conserving iron. In horses, haptoglobin is primarily produced by the liver in response to inflammation, infection, or tissue injury. Its concentration in serum rises significantly during acute-phase responses, making it a sensitive indicator of systemic inflammation. Beyond its role in hemoglobin scavenging, haptoglobin also participates in modulating the immune response and protecting tissues from oxidative stress.
The horse haptoglobin ELISA is designed to quantitatively measure haptoglobin levels in equine serum or plasma. In research settings, this assay is widely used to study inflammatory mechanisms, monitor responses to infections, and evaluate stress or tissue injury in horses. Researchers also use haptoglobin measurements to investigate the effects of disease or therapeutic interventions on the equine acute-phase response, as well as to explore correlations between inflammation and performance or recovery in athletic horses.
Clinically, haptoglobin ELISA provides a valuable tool for veterinarians to detect and monitor inflammatory conditions, infections, or hemolytic disorders in horses. It can aid in the early diagnosis of systemic inflammation before overt clinical signs appear, help assess disease severity, and monitor treatment efficacy. By providing a quantitative measure of the acute-phase response, haptoglobin levels complement other diagnostic tests, guiding clinical decision-making and improving the management of equine health.
This product is manufactured in USA by Eagle Biosciences.
| Size | 1 x 96 Well |
| Sensitivity | 2.726 ng/mL |
| Dynamic Range | 18.75 ng/mL – 600 ng/mL |
| Incubation Time | 1 hour 10 minutes |
| Sample Type | Serum, plasma |
| Storage | 2-8°C |
| Alternative Names | Hp, Hpt, and α2-HS glycoprotein. |